2022, ' Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort ', Heart, vol. 108, no. 12, pp. 923-931 . https://doi.org/10.1136/heartjnl-2021-320325 2022, ' Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort ', Heart (British Cardiac Society), vol. 108, no. 12, heartjnl-2021-320325, pp. 923-931 . https://doi.org/10.1136/heartjnl-2021-320325